291 related articles for article (PubMed ID: 32886340)
1. Can Ratios Between Prognostic Factors Predict the Clinical Pregnancy Rate in an IVF/ICSI Program with a GnRH Agonist-FSH/hMG Protocol? An Assessment of 2421 Embryo Transfers, and a Review of the Literature.
Merviel P; Menard M; Cabry R; Scheffler F; Lourdel E; Le Martelot MT; Roche S; Chabaud JJ; Copin H; Drapier H; Benkhalifa M; Beauvillard D
Reprod Sci; 2021 Feb; 28(2):495-509. PubMed ID: 32886340
[TBL] [Abstract][Full Text] [Related]
2. Dual trigger for final oocyte maturation improves the oocyte retrieval rate of suboptimal responders to gonadotropin-releasing hormone agonist.
Lu X; Hong Q; Sun L; Chen Q; Fu Y; Ai A; Lyu Q; Kuang Y
Fertil Steril; 2016 Nov; 106(6):1356-1362. PubMed ID: 27490046
[TBL] [Abstract][Full Text] [Related]
3. 450 IU versus 600 IU gonadotropin for controlled ovarian stimulation in poor responders: a randomized controlled trial.
Lefebvre J; Antaki R; Kadoch IJ; Dean NL; Sylvestre C; Bissonnette F; Benoit J; Ménard S; Lapensée L
Fertil Steril; 2015 Dec; 104(6):1419-25. PubMed ID: 26361207
[TBL] [Abstract][Full Text] [Related]
4. Use of Utrogestan during controlled ovarian hyperstimulation in normally ovulating women undergoing in vitro fertilization or intracytoplasmic sperm injection treatments in combination with a "freeze all" strategy: a randomized controlled dose-finding study of 100 mg versus 200 mg.
Zhu X; Ye H; Fu Y
Fertil Steril; 2017 Feb; 107(2):379-386.e4. PubMed ID: 27865446
[TBL] [Abstract][Full Text] [Related]
5. Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles.
Lin MH; Wu FS; Lee RK; Li SH; Lin SY; Hwu YM
Fertil Steril; 2013 Nov; 100(5):1296-302. PubMed ID: 23993928
[TBL] [Abstract][Full Text] [Related]
6. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
[TBL] [Abstract][Full Text] [Related]
7. Does an FSH surge at the time of hCG trigger improve IVF/ICSI outcomes? A randomized, double-blinded, placebo-controlled study.
Qiu Q; Huang J; Li Y; Chen X; Lin H; Li L; Yang D; Wang W; Zhang Q
Hum Reprod; 2020 Jun; 35(6):1411-1420. PubMed ID: 32383771
[TBL] [Abstract][Full Text] [Related]
8. Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization or intracytoplasmic sperm injection.
Qin N; Chen Q; Hong Q; Cai R; Gao H; Wang Y; Sun L; Zhang S; Guo H; Fu Y; Ai A; Tian H; Lyu Q; Daya S; Kuang Y
Fertil Steril; 2016 Aug; 106(2):334-341.e1. PubMed ID: 27114329
[TBL] [Abstract][Full Text] [Related]
9. Is the effect of premature elevated progesterone augmented by human chorionic gonadotropin versus gonadotropin-releasing hormone agonist trigger?
Connell MT; Patounakis G; Healy MW; DeCherney AH; Devine K; Widra E; Levy MJ; Hill MJ
Fertil Steril; 2016 Sep; 106(3):584-589.e1. PubMed ID: 27178228
[TBL] [Abstract][Full Text] [Related]
10. Optimizing FSH Concentration Modulation in the Short-Acting GnRH-a Long Protocol for IVF/ICSI: A Retrospective Study.
Hu L; Bai L; Qin R; Wang X; Zhou J; Yu C; Chen Y; Wang S; Zhao S; Chen L; Lu R
Adv Ther; 2024 Jan; 41(1):215-230. PubMed ID: 37884809
[TBL] [Abstract][Full Text] [Related]
11. Gonadotropin-releasing hormone antagonist versus progestin for the prevention of premature luteinising hormone surges in poor responders undergoing in vitro fertilisation treatment: study protocol for a randomised controlled trial.
Wang Y; Kuang Y; Chen Q; Cai R
Trials; 2018 Aug; 19(1):455. PubMed ID: 30134964
[TBL] [Abstract][Full Text] [Related]
12. Comparison of short and long ovulation induction protocols used in ART applications according to the ovarian response and outcome of pregnancy.
Tavmergen E; Göker EN; Sendag F; Sendag H; Levi R
Arch Gynecol Obstet; 2002 Jan; 266(1):5-11. PubMed ID: 11998967
[TBL] [Abstract][Full Text] [Related]
13. Supplementation with human menopausal gonadotropin in the gonadotropin-releasing hormone antagonist cycles of women with high AMH: Pregnancy outcomes and serial hormone levels.
Chen LH; Chin TH; Huang SY; Yu HT; Chang CL; Huang HY; Wang HS; Soong YK; Wu HM
Taiwan J Obstet Gynecol; 2021 Jul; 60(4):739-744. PubMed ID: 34247817
[TBL] [Abstract][Full Text] [Related]
14. The ratio of exogenous Luteinizing hormone to Follicle stimulating hormone administered for controlled ovarian stimulation is associated with oocytes' number and competence.
Albu D; Albu A
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31850491
[TBL] [Abstract][Full Text] [Related]
15. Cycle day, estrogen level, and lead follicle size: analysis of 27,790 in vitro fertilization cycles to determine optimal start criteria for gonadotropin-releasing hormone antagonist.
Lyttle Schumacher BM; Mersereau JE; Steiner AZ
Fertil Steril; 2018 Apr; 109(4):633-637. PubMed ID: 29605403
[TBL] [Abstract][Full Text] [Related]
16. GnRH antagonist rescue of a long-protocol IVF cycle and GnRH agonist trigger to avoid ovarian hyperstimulation syndrome: three case reports.
Martínez F; Rodríguez DB; Buxaderas R; Tur R; Mancini F; Coroleu B
Fertil Steril; 2011 Jun; 95(7):2432.e17-9. PubMed ID: 21513932
[TBL] [Abstract][Full Text] [Related]
17. Comparison of GnRH agonists and antagonists in unselected IVF/ICSI patients treated with different controlled ovarian hyperstimulation protocols: a matched study.
Del Gadillo JC; Siebzehnrübl E; Dittrich R; Wildt L; Lang N
Eur J Obstet Gynecol Reprod Biol; 2002 May; 102(2):179-83. PubMed ID: 11950487
[TBL] [Abstract][Full Text] [Related]
18. Is there a place for corifollitropin alfa in IVF/ICSI cycles? A systematic review and meta-analysis.
Mahmoud Youssef MA; van Wely M; Aboulfoutouh I; El-Khyat W; van der Veen F; Al-Inany H
Fertil Steril; 2012 Apr; 97(4):876-85. PubMed ID: 22277766
[TBL] [Abstract][Full Text] [Related]
19. IVF/ICSI outcomes between cycles with luteal estradiol (E2) pre-treatment before GnRH antagonist protocol and standard long GnRH agonist protocol: a prospective and randomized study.
Ye H; Huang GN; Zeng PH; Pei L
J Assist Reprod Genet; 2009 Mar; 26(2-3):105-11. PubMed ID: 19225876
[TBL] [Abstract][Full Text] [Related]
20. Timing of human chorionic gonadotropin (hCG) hormone administration in IVF/ICSI protocols using GnRH agonist or antagonists: a systematic review and meta-analysis.
Chen Y; Zhang Y; Hu M; Liu X; Qi H
Gynecol Endocrinol; 2014 Jun; 30(6):431-7. PubMed ID: 24731070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
